Browsing "2. Conference Papers" by 발행일 :
전체 결과 28건 중 1-20 번을 표시중입니다.
-
1
Conference
Nationwide real-world practice pattern and clinical data of palbociclib in patients with HR(+), HER2(-) metastatic breast cancer (KCSG BR21-15)
김한조
2024
-
2
Conference
Hidden advertisements included in cancer information posts: Insights from social listening
이상철
2024
-
3
Conference
A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo) adjuvant therapy in patients with early triple-negative breast cancer: Korean Cancer Study Group BR 15-1 PEARLY trial
김한조
2024
-
4
Conference
Modified FOLFIRINOX versus S-1 as second-line chemotherapy in patients with gemcitabine-failed metastatic pancreatic cancer: A randomized phase III trial (MPACA-3)
이상철
2021
-
5
Conference
Relationship between RAS, BRAF, PIK3CA and location of primary tumor in urothelial carcinoma
이상철
2019
-
6
Conference
Three-dimensional high-throughput drug screening for bladder cancer
이상철
2019
-
7
Conference
A randomized phase II study of palbociclib plus exemestane with GNRH agonist versus capecitabine in premenopausal women with hormone receptor-positive metastatic breast cancer (KCSG-BR 15-10, NCT02592746)
김한조
2019
-
8
Conference
A randomized phase II clinical trial of gemcitabine, oxaliplatin, erlotinib combination chemotherapy versus gemcitabine and erlotinib in previously untreated patients with locally advanced or metastatic pancreatic cancer
김한조
;
이상철
;
배상병
;
et al
2018
-
9
Conference
Pilot trial of epidermal growth factor (EGF) ointment for the patients with epidermal growth factor receptor (EGFR) inhibitor related skin side effects
이상철
2018
-
10
Conference
Comprehensive analysis of mutation and expression based pathways in head and neck squamous cell carcinoma
이상철
2018
-
11
Conference
PEARLY: A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo)adjuvant therapy in patients with early triple-negative breast cancer
김한조
2017
-
12
Conference
Division of elderly patients in colorectal cancer: Korean national health insurance big data analysis
이상철
;
배상병
2017
-
13
Conference
In vitro functional study of novel oncogene serine protease 33 (PRSS33) and the clinical significance of PRSS33 expression in colorectal cancer patients
김한조
;
안태성
;
전섭
;
et al
2016
-
14
Conference
Defensin-alpha 6 (DEFA6) as a protumorigenic function in vitro and prognostic marker in colorectal cancer
김한조
;
안태성
;
전섭
;
et al
2016
-
15
Conference
Attenuated FOLFIRINOX (5-FU/LV, irinotecan and oxaliplatin) as second-line chemotherapy for the Koreans (Asian population) with gemcitabine-resistant or –refractory advanced pancreatic cancer
이상철
;
이규택
;
배상병
;
et al
2016
-
16
Conference
Modified FOLFIRINOX (5-FU/LV, irinotecan and oxaliplatin) as second-line chemotherapy for gemcitabine-resistant or -refractory advanced pancreatic cancer
이상철
;
이규택
;
배상병
;
et al
2015
-
17
Conference
Prospective multicenter study evaluating adrenal suppression after dexamethasone therapy as an antiemetic in cancer patients: a KSWOG (Korean South West Oncology Group) study
이규택
;
배상병
;
김한조
2015
-
18
Conference
In vitro functional study of Ang 2 in colorectal cancer cell line and the significance of Ang 2 expression in colorectal cancer patients
백무준
;
김창진
;
김한조
;
et al
2014
-
19
Conference
Overexpression of nuclear karyopherin alpha2 correlates with poor prognosis in patients with colorectal cancer
백무준
;
김창진
;
김한조
;
et al
2014
-
20
Conference
A phase II study of gemcitabine, oxaliplatin, and erlotinib (GEMOX-T) combination chemotherapy in previously untreated patients with locally advanced unresectable or metastatic pancreatic cancer
김한조
;
이상철
;
배상병
;
et al
2014